Secret Bio-Research Funding: What We Found
22 Dec 2025
By
Sarah Whitcombe
Medical and Scientific Analysis
Keywords: secret funding,bio-research,EcoHealth Alliance,DARPA,gain of function,research transparency
Sarah Whitcombe specialises in medical, pharmaceutical, and public health controversies with a focus on regulatory failures.
We examine hidden streams of funding for biological research, distinguish peer reviewed facts from expert views and informed speculation, and list sources.
We believe funding pathways shape what science can and cannot be done. Our team has traced a pattern where public, private and classified funds mix in ways that reduce transparency. In this briefing we outline peer reviewed studies that sparked policy debates, name institutions and researchers involved in contested collaborations, and separate expert commentary from reasonable speculation. We aim to inform readers who follow hidden agendas without making medical claims or offering advice. Below we set out the evidence and our cautious inferences.
Peer reviewed research and recognised controversies
We start with established publications that changed how agencies funded risky biological work. Two 2012 papers triggered global debate. Herfst et al. reported airborne transmission of H5N1 between ferrets in Science (Herfst et al., Science 2012) and Imai et al. described mammalian adaptation of H5 in Nature (Imai et al., Nature 2012). Those studies are cited by policy makers when discussing potential risks of certain laboratory experiments.
In response the US government introduced stricter review processes. The pause on some gain of function funding in 2014 and the later HHS P3CO framework are public policy steps that followed the scientific debate. These are documented in government and mainstream science outlets and they are not secret.
Named actors and funding pathways
We document named institutions that appear in public records. The EcoHealth Alliance, led by Dr Peter Daszak, received NIH funding to study coronaviruses and to collaborate with overseas laboratories including the Wuhan Institute of Virology. That funding and later pauses or terminations were reported in outlets such as Nature and appear in NIH grant records. The US Defence Advanced Research Projects Agency, DARPA, runs programmes such as Insect Allies which have public project pages and generated discussion about agricultural biosecurity.
These very public items show how university researchers, NGOs and government research agencies can work together. At the same time some channels of support are classified or restricted and do not appear in public grant databases.
Expert opinion and institutional statements
We separate commentary from evidence. Experts quoted in science journalism have expressed concern about dual use research and about transparency in international collaborations. For example WHO teams led by Peter Ben Embarek have commented on lab and field work during origins investigations. DARPA and other agencies have posted their own descriptions of programmes when challenged publicly.
These expert opinions and institutional statements help interpret the record. They are not peer reviewed experiments, but they matter because they shape policy and oversight.
Where we move from evidence to informed speculation
We speculate cautiously about how covert or compartmentalised funding may occur. It is plausible that national security budgets and classified contracts create blind spots in public grant databases. We also consider how private foundations or intermediaries might fund partnerships that lack full public disclosure. These suggestions are logical inferences based on how procurement and research contracting normally operate. They are not proven facts in individual cases.
We deliberately avoid making medical or health claims. We do not offer any instructions. Our goal is to map who appears in the public funding record and to highlight where opacity remains.
Sign up to our newsletter for daily briefs.
References and sources
